GRIFTER ALERT: Brigham Buhler Peddles Big Pharma Trash Under ‘MAHA’ Branding
Shane Trejo
|
With the rise of the Make America Healthy Movement (MAHA) pioneered by Health and Human Services Secretary Robert F. Kennedy Jr. and then absorbed by President Donald Trump, there is a bigger skepticism with the public health establishment than ever before, and these people are becoming a political constituency as well as a market hungry for alternatives to the status quo.
Enter Brigham Buhler. Buhler is the founder of Revive RX Pharmacy and the telehealth clinic Ways2Well. He portrays himself as a freedom fighter, a champion of the MAHA agenda who is taking on Big Pharma on behalf of the downtrodden.
Buhler has made the rounds, appearing on the Tucker Carlson show, the Joe Rogan Experience and Alex Jones’ Infowars. He says the right talking points and gives an impressive spiel during these appearances, but what lurks beneath the surface is a grift that exploits the MAHA movement toward an enterprise that may even be more corrupt and harmful than Big Pharma.
During his interviews, Buhler regularly blasts the Food and Drug Administration (FDA) as a corrupt organization with a pro-corporate agenda.
“A majority of the FDA’s funding comes from private industry… And they are being influenced by these companies,” Buhler said while being interviewed by Joe Rogan.
Buhler has ran afoul of the FDA on several occasions. The FDA accused Buhler’s Revive RX of operating under insanitary conditions in their drug manufacturing area in 2023. They were accused in the same complaint of selling drugs that had not been properly regulated or approved by the FDA, including human chorionic gonadotropin (HCG) and Thymosin-Beta 4 (TB4).
While these instances could be reasonably explained away as the FDA coming after a pesky whistleblower exposing their corruption, a drug recall from just last year shows the true nature of Buhler’s firm.
Revive RX initiated a nationwide Class I recall in April 2024 because they had mislabeled a medication used for injections. Buhler’s pharmacy was revealed to have been selling vials of Tirzepatide under false pretenses. Tirzepatide is a weight-loss and diabetes drug similar to Mounjaro, rapidly growing in popularity as America’s obese population looks for pharmacological solutions to their lack of self-control.
Instead of providing patients with Tirzepatide, Buhler’s organization mistakenly provided patients with hormone steroids. This mistake was determined by the FDA to constitute “a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”
“It’s a serious error to mislabel a pharmaceutical in this way and it suggests that they have lax processes and procedures in place,” said FDA Commissioner Stephen Ostroff.
The recall covered 751 vials that had been shipped across the country. Eli Lilly and Company has sued Revive RX over allegations that Buhler is illegally copying Big Pharma’s drugs and then reselling them under the guise of “compounding.”
Buhler’s compounding schemes backfired during the Class 1 recall of his Tirzepatide copycat drug. But this also begs the question: Why is Buhler, supposedly a health fanatic, giving patients the same type of drugs as Big Pharma? Instead of developing an authentic alternative or an innovation, Buhler appears to be slapping MAHA branding over dangerous Big Pharma slop and somehow making it even more hazardous out of laziness and ineptitude.
Buhler is the latest example of “MAGA-washing,” or in this case “MAHA-washing,” where disreputable figures attempt to portray themselves as MAGA or MAHA mavericks in an attempt to win over the growing population of individuals with distrust of the political, medical and corporate establishment. Examining Buhler’s record, it becomes clear that he is no innocent victim of the FDA, and his repeated run-ins with the feds come from his shoddy business practices rather than legitimate victimhood.
Share: